Predictive Oncology Inc. POAI
Set alert
4.91 USD 0.00 0.00%
As of Apr 21, 3:59 PM ET
4.21 Day range 4.98
52-week range unavailable
- YTD
- +498.78%
- 1 year
- +520.73%
- Open
- 4.49
- Prev close
- 4.91
- Mkt cap
- 3.57M
- Vol
- 19.09K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.21
- High
- 4.98
- Forward P/E
- -5.72
- Beta
- 1.15
- Short ratio
- 1.26
- Inst. own
- 4.01%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.73052
- 200-d avg
- 1.21
- 1y target
- 0.00
2Y chart
Events in this range
- Mar 28, 2024Earnings: -0.85; estimate 0; surprise —%
- May 14, 2024Earnings: -1.04; estimate 0; surprise —%
- Aug 13, 2024Earnings: -0.68; estimate 0; surprise —%
- Aug 19, 2024Rating: HC Wainwright & Co. · — → Buy
- Nov 12, 2024Earnings: -0.36; estimate -0.32; surprise -12.5%
- Nov 15, 2024Downgrade: HC Wainwright & Co. · Buy → Neutral
- Sep 30, 2025Split: 1 for 15
Signals (83)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Dec 5, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 13, 2025 | 11 months ago |
| RSI: Oversold | Nov 5, 2025 | 12 months ago |
| RSI: Oversold | Oct 23, 2025 | 1 year ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Sep 30, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 26, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 26, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| RSI: Overbought | Sep 22, 2025 | 1 year ago |
| RSI: Overbought | Sep 9, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 13, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
Newest 20 of 83.
Key statistics
- Market cap
- 4.57M
- Enterprise value
- 2.77M
- Trailing P/E
- 0.00
- Forward P/E
- -5.72
- PEG ratio
- 0.00
- Price / sales
- 2.62
- Price / book
- 0.34
- EPS (TTM)
- -2.96
- Beta
- 1.15
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.75M
- Revenue growth
- -43.10%
- Free cash flow
- -7.75M
- Total cash
- 5.33M
- Total debt
- 2.70M
- Return on equity
- -149.36%
- Shares outstanding
- 6.67M
- Short % of float
- 2.27%
- 50-day average
- 0.73052
- 200-day average
- 1.21
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
POAI Revenue — quarterly 3.62K
POAI Net income — quarterly -77.65M
POAI EPS — quarterly -107.25
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.32 | -0.36 | -0.04 | -12.50% |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.68 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -1.04 | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | -0.85 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -0.78 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | -0.95 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | down | Buy | Neutral |
| Aug 19, 2024 | HC Wainwright & Co. | init | — | Buy |
About Predictive Oncology Inc.
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- predictive-oncology.com
News
- Why RF Industries Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Nasdaq Jumps 150 Points; US Pending Home Sales Rise
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Friday's After-Market Session
Your note
Sign in to keep a note on POAI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHUNG-WELCH NANCY | Director | Stock Award(Grant) | Apr 4, 2024 | 21,237 |
| HANDLEY DANIEL E | Director | Stock Award(Grant) | Apr 4, 2024 | 18,661 |
| HAWRYLUK MATTHEW | Director | Stock Award(Grant) | Apr 4, 2024 | 9,488 |
| MYERS ROBERT L | Chief Financial Officer | Conversion of Exercise of derivative security | Sep 24, 2023 | 4,720 |
| NUZUM CHARLES LEE SR | Director | Stock Award(Grant) | Apr 4, 2024 | 31,921 |
| RAO VEENA | Director | Stock Award(Grant) | Apr 4, 2024 | 9,117 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 1.07% | 71,307 | 48.92K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.78% | 51,868 | 35.58K | Sep 29, 2024 |
| Susquehanna International Group, LLP | 0.22% | 14,948 | 10.25K | Sep 29, 2024 |
| State Street Corporation | 0.21% | 13,837 | 9.49K | Sep 29, 2024 |
| Csenge Advisory Group | 0.19% | 13,000 | 8.92K | Sep 29, 2024 |
| Two Sigma Investments, LP | 0.19% | 12,560 | 8.62K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.05% | 69,881 | 47.94K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.52% | 34,894 | 23.94K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.14% | 9,279 | 6.37K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.06% | 3,782 | 2.59K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 2,138 | 1.47K | Oct 30, 2024 |